Financial

Nasdaq-listed biotech company Curis (CRIS:NASDAQ) saw its share price expand by 17% Thursday morning after the company announced a collaboration with Aurigene.

The news propelled Curis’ market to its most liquid trading day in over a month as better than 2.5 million shares traded hands.